Cite

HARVARD Citation

    Tran, K. et al. (2018). Proton pump inhibitor and histamine‐2 receptor antagonist use and risk of liver cancer in two population‐based studies. Alimentary pharmacology & therapeutics. 48 (1), pp. 55-64. [Online]. 
  
Back to record